Understanding the fundamentals of cancer biology and tumour classification
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Cancer is a disease characterised by unrestrained and excessive multiplication of body cells. It may occur in any body tissue and at any age, although cancer is found most frequently in older people.
Cancerous cells accumulate as growths called malignant tumours, which penetrate, compress, and ultimately destroy the surrounding normal tissue. In addition to their local growth, cancerous cells also have the ability to spread throughout the body by way of the bloodstream or lymphatic vessels.


© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Tumours, also called neoplasms, are masses or growths that arise from normal tissue. They represent abnormal cellular proliferation that can vary significantly in their behaviour and clinical significance.
Nonprogressive and not life-threatening
Early cancer without invasion
Progressive and life-threatening
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Benign tumours are nonprogressive and not life-threatening. They remain localised and do not pose significant health risks to patients.
Often encapsulated within a fibrous capsule or cover so that the tumour cells do not invade the surrounding tissue. This containment prevents spread.
These tumours grow slowly and predictably, allowing for easier monitoring and management by healthcare professionals.
Composed of highly organised and specialised (differentiated) cells, which closely resemble normal, mature tissue in structure and function.
Cells from benign tumours do not spread to form secondary tumour masses in other places in the body, limiting their impact.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Pre-malignant or Carcinoma in situ (CIS) is an early form of cancer that is defined by the absence of invasion of tumour cells into the surrounding tissue.
The neoplastic cells proliferate in their normal habitat, hence the name "in situ". For example, carcinoma in situ of the skin is the accumulation of neoplastic epidermal cells within epidermis only, that has failed to penetrate into the deeper dermis.
Critical Understanding: CIS is considered a precursor or incipient form of cancer that may, if left untreated long enough, transform into a malignant neoplasm.
Many forms of invasive carcinoma (the most common form of cancer) originate after progression of a CIS lesion. Therefore, early detection and treatment of CIS is crucial in preventing cancer development.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Malignant tumours represent the most serious form of neoplastic growth, characterised by aggressive behaviour and life-threatening potential.
Life-threatening and continuously advancing
Malignant tumour cells multiply rapidly and uncontrollably
Extends beyond tissue of origin into adjacent organs
Resemble embryonic cells without mature functions
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com

Malignant tumours can detach themselves from the primary (original) tumour site, travel through the bloodstream and lymphatic system, and establish a new tumour site at a distant region within the body.
Spread of malignant tumour to a secondary site is called metastasis. This ability to metastasise is what makes malignant tumours particularly dangerous and difficult to treat.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Cancers are classified by the type of cell that the tumour cells resemble and is therefore presumed to be the origin of the tumour. This classification system helps clinicians determine appropriate treatment strategies and predict patient outcomes.
Derived from epithelial cells
Arising from connective tissue
From blood-forming cells
Derived from pluripotent cells
From immature precursor cells
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Carcinomas are cancers derived from epithelial cells. This group includes many of the most common cancers, particularly in the aged population.
Epithelial cells form the lining of body surfaces, cavities, and organs. When these cells become cancerous, they can develop into various types of carcinomas affecting different organs.
Carcinomas account for approximately 80-90% of all cancer diagnoses, making them the most prevalent cancer type worldwide.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Sarcomas are cancers arising from connective tissue, including bone, cartilage, fat, and nerve tissue. Each type develops from cells originating in mesenchymal cells outside the bone marrow.
Osteosarcoma and Ewing's sarcoma affecting skeletal structures
Chondrosarcoma developing in cartilaginous tissue
Liposarcoma and fibrosarcoma in fat and fibrous tissues
Sarcomas are relatively rare, accounting for less than 1% of all adult cancers, but are more common in children and young adults.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Lymphomas arise from haematopoietic (blood-forming) cells that leave the marrow and tend to mature in the lymph nodes.

Leukaemias arise from haematopoietic cells that leave the marrow and tend to mature in the blood.

© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Germ cell tumours are cancers derived from pluripotent cells, most often presenting in the reproductive organs. These tumours arise from the cells that give rise to eggs and sperm.
Seminoma is the most common type, typically affecting men between 25-45 years of age.
Dysgerminoma is the ovarian equivalent, though less common than seminoma.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com

Blastomas are cancers derived from immature "precursor" cells or embryonic tissue. These tumours are most common in children, as they arise from cells that should have matured during foetal development.
The suffix "-blastoma" indicates that the tumour originates from immature, embryonic-like cells that have retained their ability to divide rapidly.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Understanding the progression from normal cells to invasive cancer helps in early detection and intervention strategies.
Healthy cells with controlled growth and proper function
Increased cell division but cells remain normal
Abnormal cell appearance and organisation
Cancer cells present but not invasive
Cancer cells invade surrounding tissue
Cancer spreads to distant sites
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Understanding cancer classification is crucial for healthcare professionals in determining appropriate treatment strategies and predicting patient outcomes.
Different cancer types respond to different treatments. Carcinomas may require surgery and chemotherapy, whilst leukaemias often need targeted drug therapy.
Classification helps predict disease progression and survival rates. Germ cell tumours have excellent prognosis, whilst some sarcomas are more challenging.
Proper classification enables targeted research into specific cancer types, leading to development of more effective, personalised treatment approaches.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Cells closely resemble normal, mature tissue with organised structure and specialised functions.

Cells resemble primitive, embryonic cells without capacity for mature cellular functions.

© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Whilst cancer can occur at any age, the incidence varies significantly across different age groups and cancer types.
The chart demonstrates that cancer incidence increases dramatically with age, with older populations experiencing significantly higher rates. This is due to accumulated genetic mutations and decreased immune surveillance over time.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Tumour grows outward, pushing surrounding tissue aside. Common in benign tumours with encapsulation.
Tumour cells invade between normal tissue cells, destroying structure. Characteristic of malignant tumours.
Tumour cells break away and establish secondary growths at distant sites through blood or lymph.
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Understanding how cancer spreads is essential for treatment planning and preventing metastasis.
Through bloodstream to distant organs
Through lymph vessels to regional nodes
Invasion into adjacent tissues and organs
Across body cavities like peritoneum
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Physical assessment and patient history to identify suspicious signs and symptoms
X-rays, CT scans, MRI, and PET scans to visualise tumour location and extent
Blood tests, tumour markers, and biochemical analysis to support diagnosis
Microscopic examination of tissue sample for definitive diagnosis and classification
Genetic and molecular analysis to guide targeted therapy selection
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Understanding the global burden of cancer helps in resource allocation and public health planning.
Global cancer incidence continues to rise
Cancer remains a leading cause of mortality
5-year prevalence worldwide
Most common cancer type
Sarcomas, lymphomas, leukaemias
Germ cell and blastomas
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Many cancers can be prevented or detected early through lifestyle modifications and screening programmes.
Single most important preventable cause
Rich in fruits, vegetables, and whole grains
Maintain healthy body weight
Reduce consumption to lower risk
Prevent skin cancer development
Breast cancer screening for women
Colorectal cancer detection
Cervical cancer screening
Prostate cancer monitoring
Melanoma early detection
© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com
Connect with the JVAGES Health Learning and Development Team — reach us directly, explore our website, or download the app to start learning today.

+91-9043464563 or +91-8015029971
admin@agescodingtech.com

© JVAGES Health Learning and Development Team. For Course Enquiry and Schedule Demo - +91-9043464563 or +91-8015029971 or admin@agescodingtech.com